Xaver U Kahle

Years Active: 2019-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Mirian Brink, Xaver U Kahle, Joost S P Vermaat, Josée J M Zijlstra-Baalbergen, Martine Chamuleau, Marie José Kersten, Müjde Durmaz, Wouter J Plattel, Pieternella J Lugtenburg, Wendy Stevens, Rogier Mous, Elisabeth G E de Vries, Marjolein W M van der Poel, Prashant V Nannan Panday, Gerwin Huls, Tom van Meerten, Marcel Nijland
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study. Blood advances 5 (15) (2021)
Xaver U Kahle, Menno Hovingh, Walter Noordzij, Annika Seitz, Arjan Diepstra, Lydia Visser, Anke van den Berg, Tom van Meerten, Gerwin Huls, Ronald Boellaard, Thomas C Kwee, Marcel Nijland
Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements. European radiology 29 (11) (2019)

Xaver U Kahle.css-eqlu8i{font-size:small;padding-left:4px;}